Nplate, injection (romiplostim) - New product

Source: eMC (electronic Medicines Compendium)

Date published: 20/10/2009 09:51

Type of SPC Change: New Product

Generic drug name: Romiplostim

Drug brand name: Nplate

Legal status: POM - Black Triangle

Pharmaceutical manufacturer: Amgen Limited

Summary
by: Clare Greenwood

Nplate (romiplostim) is indicated for adult chronic immune (idiopathic) thrombocytopenic purpura (ITP) splenectomised patients who are refractory to other treatments (e.g. corticosteroids, immunoglobulins).

Nplate may be considered as second line treatment for adult non-splenectomised patients where surgery is contra-indicated.

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.